p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma

Journal of Cutaneous Pathology

Volumn 33, Issue 6, 2006, Pages 413-417

  Dotto, Jorge E ^a   Glusac, Earl J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; CYTOKERATIN 903; CYTOKERATIN MNF 116; PROTEIN P63; PROTEIN S 100; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AGED; ARTICLE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROXANTHOMA; HUMAN; HUMAN CELL; LEIOMYOSARCOMA; MALE; MELANOMA; PROTEIN EXPRESSION; SKIN CARCINOMA; SKIN TUMOR; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; DERMATOFIBROSARCOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MALE; MELANOMA; MEMBRANE PROTEINS; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; XANTHOMATOSIS;

EID: 33744976087     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2006.00477.x     Document Type: Article

References (18)

1. Brash DE Rudolph JA Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991 88 6 10124.
2. Rosai J. Rosai and Ackerman's Surgical Pathology, 9th edn. Mosby, UK 2004.
3. Sigel JE Skacel M Bergfeld WF House NS Rabkin MS Goldblum JR. The utility of cytokeratin 5/6 in the recognition of cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 2001 28 10 520.
4. Prieto VG Lugo J McNutt NS. Intermediate- and low- molecular-weight keratin detection with the monoclonal antibody MNF116. An immunohistochemical study on 232 paraffin-embedded cutaneous lesions. J Cutan Pathol 1996 23 3 234.
5. Martin HE Stewart FW. Spindle cell epidermoid carcinoma. Am J Cancer 1935 24: 273.
6. Wick MR Fitzgibbon J Swanson PE. Cutaneous sarcomas and sarcomatoid neoplasms of the skin. Semin Diagn Pathol 1993 10 2 148.
7. Koster M Roop D. The role of p63 in development and differentiation of the epidermis. J Dermatol Sci 2004 34: 3.
8. Takeuchi Y Tamura A Kamiya M Suzuki K Ishikawa O. Immunohistochemical analyses of p63 expression in normal human skin. Br J Dermatol 2004 151 1 232.
9. Pellegrini G Dellambra E Golisano O, et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 2001 98 6 3156.
10. Reis-Filho JS Torio B Albergaria A Schmitt FC. p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 2002 29 9 517.
11. Park HR Min SK Cho HD Kim KH Shin HS Park YE. Expression profiles of p63, 53, survivin, and hTERT in skin tumors. J Cutan Pathol 2004 31 8: 544.
12. Westfall MD Pietenpol JA. p63: molecular complexity in development and cancer. Carcinogenesis 2004 25 6 857.
13. Sniezek JC Matheny KE Westfall MD Pietenpol JA. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Laryngoscope 2004 114 12 2063.
14. Gwosdz C Balz V Scheckenbach K Bier H. p53, 63 and p73 expression in squamous cell carcinomas of the head and neck and their response to cisplatin exposure. Adv Otorhinolaryngol 2005 62: 58.
15. Longacre TA Egbert BM Rouse RV. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study. Am J Surg Pathol 1996 20 12 1489.
16. Skelton HG Maceira J Smith KJ McCarthy WF Lupton GP Graham JH. HMB45 negative spindle cell malignant melanoma. Am J Dermatopathol 1997 19 6 580.
17. Calonje E Wadden C Wilson-Jones E Fletcher CD. Spindle-cell non-pleomorphic atypical fibroxanthoma: analysis of a series and delineation of a distinctive variant. Histopathology 1993 22 3 247.
18. Smith KJ Skelton HG III Morgan AM Barrett TL Lupton GP. Spindle cell neoplasms coexpressing cytokeratins and vimentin (metaplastic squamous cell carcinoma). J Cutan Pathol 1992 19: 286.